Cancer Flashcards
Q: What are the most common tumors causing bone metastases in descending order?
A: Prostate, breast, lung
Q: What are the most common sites of bone metastases in descending order?
A: Spine, pelvis, ribs, skull, long bones
Q: Besides bone pain, what are other features of bone metastases?
A: Pathological fractures, hypercalcaemia, raised ALP
Q: What cancer is associated with aflatoxin produced by Aspergillus?
A: Hepatocellular carcinoma (liver cancer)
Q: What cancer is linked to aniline dyes exposure?
A: Bladder cancer (transitional cell carcinoma)
Q: What cancers are associated with asbestos exposure?
A: Mesothelioma and bronchial carcinoma
Q: What cancers are linked to nitrosamines?
A: Oesophageal and gastric cancer
Q: What cancer is associated with vinyl chloride exposure?
A: Hepatic angiosarcoma
Q: What is the most important risk factor for developing cervical cancer?
A: Human papillomavirus (HPV) infection
Q: Which HPV subtypes are particularly carcinogenic for cervical cancer?
A: Subtypes 16, 18, and 33
Q: Which HPV subtypes are non-carcinogenic and associated with genital warts?
A: Subtypes 6 and 11
Q: What cellular changes can occur in HPV-infected endocervical cells?
A: Development of koilocytes
Q: What are the characteristics of koilocytes?
A: Enlarged nucleus, irregular nuclear membrane contour, hyperchromasia (darker staining nucleus), perinuclear halo
Q: What are common side effects of chemotherapy related to the gastrointestinal system?
A: Nausea and vomiting
Q: What are risk factors for developing nausea and vomiting with chemotherapy?
A: Anxiety, age <50 years, concurrent use of opioids, type of chemotherapy used
Q: What is a first-line treatment for chemotherapy-induced nausea and vomiting in low-risk patients?
A: Metoclopramide
Q: What medications are recommended for high-risk patients with chemotherapy-induced nausea and vomiting?
A: 5HT3 receptor antagonists (e.g., ondansetron) combined with dexamethasone
Q: What are the adverse effects of cyclophosphamide?
A: Haemorrhagic cystitis, myelosuppression, transitional cell carcinoma